Recombinant Carboxypeptidase G2 (Kerun Biopharmaceutical)

N/A

Report date: 2025/01/26 17:50:30

Base Information

Drug NameRecombinant Carboxypeptidase G2 (Kerun Biopharmaceutical)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionProstate-Specific Membrane Antigen modulators
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChongqing Kerun Biologic Pharmaceutical Development Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChongqing Kerun Biologic Pharmaceutical Development Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A